M-AMOXI CLAV

d. d. regimen (see 8 ADVERSE REACTIONS). D. D. 5 mg clavulanic acid Otitis Media** 40 mg/kg/day in divided doses every 8 hours *The bid regimen is recommended as it is associated with significantly less diarrhea. **Duration of therapy studied and recommended for acute otitis media is 10 days.

5 mg clavulanic acid and of 400 mg amoxicillin / 57 mg clavulanic acid. The normal duration of treatment was 7 to 10 days. However, in general, treatment should be continued for a minimum of 48 to 72 hours beyond the time that the patient becomes asymptomatic or evidence of bacterial eradication has been obtained.

It is recommended that there be at least 10 days treatment for any infection caused by β-hemolytic streptococci to prevent the occurrence of acute rheumatic fever or glomerulonephritis. The children's dosage should not exceed that recommended for adults.

, the usual adult dose is one (1) amoxicillin and clavulanate potassium-500 mg/125 mg tablet every 12 hours. For more severe infections and infections of the lower respiratory tract, the dose should be one (1) amoxicillin and clavulanate potassium-875 mg/125 mg tablet every 12 hours or one (1) amoxicillin and clavulanate potassium-500 mg/125 mg tablet every 8 hours).

5 mg per 5 mL)) according to body weight. 1 a Based on amoxicillin component b Dosages are expressed in terms of amoxicillin plus clavulanic acid. 5 mg). 5 mg per 5 mL) are equivalent to one (1) amoxicillin and clavulanate potassium-500 mg /125 mg tablet.

5 mg clavulanic acid per 5 mL for oral suspension or M-AMOXI CLAV (400 mg / 57 mg per 5 mL)) according to body weight. 7 a Based on amoxicillin component b Dosages are expressed in terms of amoxicillin plus clavulanic acid. 5 […]

). D. D. 5 mg clavulanic acid Otitis Media** 40 mg/kg/day in divided doses every 8 hours *The bid regimen is recommended as it is associated with significantly less diarrhea. **Duration of therapy studied and recommended for acute otitis media is 10 days.

5 mg clavulanic acid and of 400 mg amoxicillin / 57 mg clavulanic acid. The normal duration of treatment was 7 to 10 days. However, in general, treatment should be continued for a minimum of 48 to 72 hours beyond the time that the patient becomes asymptomatic or evidence of bacterial eradication has been obtained.

It is recommended that there be at least 10 days treatment for any infection caused by β-hemolytic streptococci to prevent the occurrence of acute rheumatic fever or glomerulonephritis. The children's dosage should not exceed that recommended for adults.

, the usual adult dose is one (1) amoxicillin and clavulanate potassium-500 mg/125 mg tablet every 12 hours. For more severe infections and infections of the lower respiratory tract, the dose should be one (1) amoxicillin and clavulanate potassium-875 mg/125 mg tablet every 12 hours or one (1) amoxicillin and clavulanate potassium-500 mg/125 mg tablet every 8 hours).

5 mg per 5 mL)) according to body weight. 1 a Based on amoxicillin component b Dosages are expressed in terms of amoxicillin plus clavulanic acid. 5 mg). 5 mg per 5 mL) are equivalent to one (1) amoxicillin and clavulanate potassium-500 mg /125 mg tablet.

5 mg clavulanic acid per 5 mL for oral suspension or M-AMOXI CLAV (400 mg / 57 mg per 5 mL)) according to body weight. 7 a Based on amoxicillin component b Dosages are expressed in terms of amoxicillin plus clavulanic acid. 5 mg clavulanic acid per 5 mL for oral suspension and M-AMOXI CLAV (400 mg / 57 mg per 5 mL) A calibrated dropper should be used to measure the appropriate volume for dosing.

, Hepatic/Biliary/Pancreatic. 2 CONTRAINDICATIONS M-AMOXI CLAV is contraindicated in patients: M-AMOXI CLAV (amoxicillin / clavulanate potassium) Page 5 of 41 Unclassified / Non classifié • with a history of hypersensitivity to the penicillin, or cephalosporin group of β-lactams, or to any ingredients contained in the preparation or component of the container.

For a complete listing, see 6 DOSAGE FORMS, STRENGTHS, COMPOSITION AND PACKAGING. • where infectious mononucleosis is either suspected or confirmed. • with a previous history of amoxicillin and clavulanate potassium -associated jaundice/hepatic dysfunction.

3 SERIOUS WARNINGS AND PRECAUTIONS BOX Serious Warnings and Precautions • Hypersensitivity: Serious and occasionally fatal hypersensitivity (anaphylactic) and severe cutaneous adverse reactions (SCAR) have been reported in patients receiving therapy with beta-lactams, including amoxicillin.

See 7 WARNINGS AND PRECAUTIONS, Hypersensitivity Reactions and 7 WARNINGS AND PRECAUTIONS, Skin. d. d. regimen (see

M-AMOXI CLAV is contraindicated in patients:

M-AMOXI CLAV (amoxicillin / clavulanate potassium) Page 5 of 41 Unclassified / Non classifié • with a history of hypersensitivity to the penicillin, or cephalosporin group of β-lactams, or to any ingredients contained in the preparation or component of the container.

For a complete listing, see 6 DOSAGE FORMS, STRENGTHS, COMPOSITION AND PACKAGING. • where infectious mononucleosis is either suspected or confirmed. • with a previous history of amoxicillin and clavulanate potassium -associated jaundice/hepatic dysfunction.